Abstract. The objective of this work was to study the release behavior of prednisolone from calcium-crosslinked carboxymethyl xanthan gum (CMXG) tablets in dissolution medium having different pH values prevailing in the gastrointestinal lumen. Xanthan gum (XG) was derivatized to CMXG which was then cross-linked in situ with Ca +2 ion during wet massing step of tablet preparation. Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry studies did not show any drug-polymer interaction although the drug underwent solid-state transformation during compression as evident from X-ray diffraction analysis. In vitro release study demonstrated that increase in the amount of Ca +2 ion decreased the drug release, and beyond a certain amount, the drug release increased. While increase in both drug load and tablet crushing strength decreased the drug release, increase in exposure time in acid solution of pH 1.2 increased the overall release of the drug. The mechanism of drug release was nonFickian/anomalous. The results indicated that variation in the amount of Ca +2 ion can modulate the drug release from CMXG matrix tablets as needed.
INTRODUCTION
In recent years, natural polysaccharides have evoked tremendous interest in the design of modified release drug delivery systems due to their nontoxicity, low cost, availability, biosafety, and biodegradability (1) . In addition, because of their wide range of molecular weight, varying chemical composition, and large number of derivable groups on molecular chains, polysaccharides easily lend themselves for various chemical modifications (2) . Modification of native polysaccharides, achieved through chemical derivatization (e.g., carboxymethylation, grafting, etc.), chemical cross-linking (with glutaraldehyde, epichlorhydrin), and ionic cross-linking (with Ca +2 , Ba +2 , Al +3 ions), offers many new functional properties to meet their needs in design of drug delivery system (3) . Several polysaccharides such as alginate (4, 5) , guar gum (6, 7), katira gum (8) , tamarind gum (9) , and pectin (10, 11) have been derivatized and/or cross-linked to have tailor-made products of various types for drug delivery devices.
Xanthan gum (XG) is an extracellular heteropolysaccharide produced by fermentation of gram-negative bacterium Xanthomonas campestris. Most of the investigations related to XG, either alone or in combination with other polymers, involved design of sustained-release matrix tablets (12) (13) (14) (15) . However, there is no report on release pattern of a drug from derivatized and cross-linked XG matrix.
In the present investigation, XG was derivatized to carboxymethyl xanthan gum (CMXG), cross-linked with Ca +2 ion and converted into tablet by wet granulation method. This method provides a greater possibility of more effective and different degrees of cross-linking between CMXG and metal ion.
The objective of this study was to evaluate the effect of the amount of Ca +2 ion on release behavior of prednisolone from the tablets. Another aspect of this study was to evaluate whether the cross-linked CMXG tablets could prevent or minimize premature release in the upper gastrointestinal tract and provide release of major amount of the drug in 10 h during which the tablets might reach the colon. The effect of other variables such as tablet crushing strength, drug load, and pretreatment time in acid solution was also investigated. Prednisolone (PDL) has been used as a model drug in this study.
MATERIALS AND METHODS

Materials
Prednisolone (PDL) was obtained as gift sample from Mepro Pharmaceuticals Pvt. Ltd., Mumbai, India. Xanthan gum (SD Fine Chem, Mumbai, India), monochloro acetic acid and calcium chloride dihydrate (CaCl 2 ) (Merck Specialities Pvt. Ltd., Mumbai, India), and all other chemicals of analytical grade were obtained commercially. Double-distilled water was used throughout the study. 1 
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Preparation of Tablets
Required amount of CMXG, which was derivatized from XG following the method reported earlier (16) , and PDL (passed through #60 mesh BS screen) were manually blended and converted into a damp, cohesive mass with required amount of CaCl 2 solution. The cohesive mass was passed through #18 mesh BS screen. The resulting granules were dried in a tray dryer at 60°C till the moisture content of the granules reached 2-4%. The dried granules were passed through #22 mesh BS screen, mixed with magnesium stearate, and compressed into tablet using a flat face 5.5-mm punch in a 10 station rotary minipress tablet machine (RIMEK, Karnavati Engineering Ltd., Gujarat, India). The tablets were prepared using different CMXG/CaCl 2 ratio, crushing strength (3.5-5.5 kg/cm 2 ), and drug load (5-20 mg). Fifty tablets of each formulation were prepared in duplicate. The composition of the tablets is shown in Table I .
Physical Characteristics of Tablets
Weight Variation Test
Twenty tablets were weighed individually in an electronic pan balance (XB 600 M-C, Precisa, Switzerland). The weight of each tablet was compared with the average weight of the tablets.
Crushing Strength of Tablets
Crushing strength of the tablets was determined using Monsanto type Tablet Hardness Tester (Campbell Electronics, Mumbai, India), and average value of 10 determinations was reported.
Thickness of Tablets
The thickness of each tablet was measured with a Digimatic Caliper (CD-6"CS, Mitutoyo Corporation, Japan), and average of 10 determinations was calculated.
Friability Test
Ten tablets were weighed and placed in the plastic drum of a Friabilator (EF2, Electro Lab, Mumbai, India). After 100 revolutions, the tablets were dedusted with a soft brass and reweighed. The percentage of weight loss was calculated.
PDL Content in Tablets
A tablet was crushed in a glass mortar and transferred quantitatively with methanol in a stoppered conical flask. The flask was shaken in a mechanical shaker for 4 h. The mixture was filtered and an aliquot, following suitable dilution, was analyzed at 243 nm using Microplate Spectrophotometer (Multiskan GO, Thermo Scientific, USA). The drug content was determined using a calibration curve constructed in methanol. Drug content of each of the 10 tablets was compared with the average drug content of the tablets.
Fourier Transform Infrared Analysis
Fourier transform infrared (FTIR) spectra of CMXG, PDL, physical mixture, and PDL-loaded tablet were recorded in a FTIR spectrophotometer (Perkin Elmer, RX-1, UK). The samples were mixed with KBr and converted into pellets at 6-ton pressure using a hydraulic press. The spectra were taken in the wave number region of 4,000-400 cm 
Differential Scanning Calorimetry Study
Differential scanning calorimetry (DSC) thermograms of CMXG, PDL, physical mixture, and PDL-loaded tablet were 
X-Ray Diffraction Study
The qualitative X-ray diffraction studies of CMXG, PDL, physical mixture, and PDL-loaded tablet were performed using an X-ray diffractometer (ULTIMA-III, Rigaku, Japan). The powdered samples were scanned from 5-80°diffraction angle (2θ) range under the following measurement conditions: source; Ni-filtered Cu-Kα radiation (λ=1.54 Å); voltage 45 kv; current 30 mA; and scan speed 5°/min.
In Vitro Drug Release Study
In vitro drug release study was carried out in USP-II tablet dissolution rate test apparatus (TDP-06P, Electro Lab, Mumbai, India) at 37±0.5°C and 100 rpm speed under sink condition following the method described in Indian Pharmacopoeia 2010 (17) for modified release tablet with slight modification. Considering the transit time and pH values prevailing in different segments of gastrointestinal tract, in vitro drug release study was performed in the following way. The tablets of each formulation were immersed in 700 ml HCl solution of pH 1.2 (gastric pH), and dissolution was carried out for 2 h. Thereafter, the pH of dissolution medium was brought to pH 7.4 (small intestinal pH) by adding 200 ml of 0.2 (M) trisodium orthophosphate dodecahydrate, and the dissolution study was carried out for 3 h in 900 ml solution of pH 7.4. After 5 h, the pH of the dissolution medium was adjusted to pH 6.8 (colonic pH) by adding 5 ml 2(M) HCl, and drug release study was continued up to 10 h in 905 ml of dissolution medium. During the dissolution study, a 5 ml aliquot was withdrawn from the dissolution medium at predetermined time and replaced with 5 ml of the fresh respective fluid warmed at 37°C. The aliquots were filtered through Whatman (No. 1) filter paper. The absorbance was measured at 248 nm for both acid solution and buffer solutions of pH 7.4 and 6.8 using Microplate Spectrophotometer (Multiskan GO, Thermo Scientific, USA). The amount of drug released from the tablet was determined using calibration curves drawn in the respective medium.
Statistical Analysis
Each formulation was prepared in duplicate, and each analysis was duplicated. The effect of variation in CMXG/CaCl 2 ratio on drug release was analyzed by analysis of variance (ANOVA, single factor) with the aid of GraphPad Prism (Version 3.0). Difference was considered significant when p<0.001.
Data Treatment
Diffusion Coefficient of Drug
For the determination of diffusion coefficient (D c ) of PDL from the tablets, equivalent spherical diameter (cm) of the tablets was calculated from the relationship: d=(6r c h) 1/3 , where d, r c , and h represent equivalent spherical diameter, radius, and height (cm) of the tablets, respectively. The diffusion coefficients (cm 2 /s) were determined using Eq. (1) which was used to calculate the diffusion coefficient of drug from spherical matrices (18) :
where r is the equivalent spherical radius of tablet, θ is the slope of linear portion of M t /M α versus t 1/2 plot, M t is the amount of drug released at time t (s), and M α is the total amount of drug loaded.
Drug Release Mechanism
The release data up to 60% of drug release were fitted to power law Eq. (2) (19).
where M t /M α represents the drug released at time t, k is a constant incorporating the structural and geometric characteristics of the matrix tablets, and n denotes the diffusional exponent indicative of transport mechanism. In case of tablet, n=0.45 indicates Fickian diffusion, 0.45<n<0.89 indicates non-Fickian/anomalous transport, n=0.89 is for case II transport, and n > 0.89 indicates super case II transport (20, 21) .
Mean Dissolution Time
The mean dissolution time in minute (MDT) was calculated from Eq. (3) (22) using the values n and k obtained from Eq. (2) .
RESULTS AND DISCUSSION
Physical Characteristics of Tablet
Weight variation test revealed that weight of none of the 20 tablets deviated by more than ±7.5% of the average weight (17) .
The friability of the tablets was less than 1% and within the pharmacopoeial limit (17) . However, the friability of the tablets FX6 and FX9 having lower crushing strength of 3.5 kg/ cm 2 was 1.04 and 1.12%, respectively. Thickness of the tablets did not vary by more than ±5% of the average thickness (3.56 mm).
PDL Content in Tablets
PDL content of each of the 10 tablets was within 85 to 115% of the average drug content.
Drug-Excipients Compatibility Study
Chemically, prednisolone is trihydroxy pregna-1,4-diene-3,20-dione. FTIR spectrum of the drug is shown in Fig. 1(a) . Peaks at 3,496, 3,455 and 3,356 cm −1 for three -OH groups, 1,609 cm −1 for diene, and 1,654 and 1,710 cm −1 for 3,20-dione were considered for identification of the drug. FTIR spectrum of physical mixture of PDL, CMXG, and CaCl 2 is shown in Fig. 1(b) . A broad shallow peak extending from about 3,100-3,600 cm −1 was considered for -OH groups; peaks at 1,609, 1,423, 1,334 and 1,057 cm −1 were respectively for C=O group of pyruvate, symmetric COO − group of glucuronic acid, -COstretching of O-carboxymethyl group, and -C-O-C-stretching of acetal group of CMXG. FTIR spectrum of PDL-loaded matrix tablet (Fig. 1(c) ) showed that the peaks at 3,496, 3,455 and 3,356 cm −1 for -OH groups of the drug overlapped with the broad shallow peak extending from 3,100-3,600 cm ; the peak for diene at 1,609 cm −1 appeared to overlap with C=O stretching of pyruvate of CMXG. The spectrum of the tablet also showed the presence of peaks for -CO-stretching of O-carboxymethyl and -C-O-C-stretching of acetal groups of CMXG. FTIR study indicated the presence of characteristic bands of the drug in the tablet almost at the same wave numbers.
The DSC thermograms of CMXG, PDL, physical mixture, and drug-loaded tablet are shown in Fig. 2 . Prednisolone exhibited a sharp melting endotherm at 244°C. CMXG showed an initial broad endotherm between 70 and 80°C due to loss of moisture present in CMXG. An exothermic peak due to decomposition of CMXG was obtained at around 280-282°C. However, the melting endotherm of the drug could not be clearly detected in either physical mixture or tablet. Although derivative DSC of the thermogram of the physical mixture showed the endothermic peak of the drug at 244°C, no endothermic melting peak of the drug was evident even after derivative DSC of the thermogram of the tablet. This indicates possible solid-state transformation of the drug during tableting.
The X-ray diffractograms of CMXG, PDL, physical mixture, and drug-loaded tablet are shown in Fig. 3 2θ with however reduced intensity due to dilution of drug with polymer. Drug-loaded tablet did not show any characteristic peaks of the drug. This demonstrated that the crystalline nature of the drug was retained in the physical mixture but lost in the tablet. It is inferred from the above results that crystalline PDL was converted into amorphous form during compression.
Drug Release
The results of PDL release from matrix tablets prepared with only CMXG or CMXG/CaCl 2 in different ratios are shown in Fig. 4 . The release of the drug from tablet FX1, which was prepared with only CMXG, was slow liberating 13.26±0.68% of the loaded drug in acid solution in 2 h, and Table II shows that MDT increased significantly (p<0.001) with increase in the amount of CaCl 2 , and after a certain amount of CaCl 2 , MDT decreased. When a tablet of CMXG is brought in contact with water, the carboxylic groups introduced on the backbone of the polymer as well as the existing carboxylic group on the trisaccharide side chain ionize, repel each other and leads to uncoiling of the double-helix structure of xanthan molecules exposing many hydrophilic groups in water and inducing hydrogen bond formation. Such interaction leads to the formation of viscous polymer solution around the tablet surface (23, 24) . Release of drug from a hydrophilic matrix tablet depends on the viscosity of the swollen region that in turn is a function of the amount of polymer in the matrix (15) . Since FX1 tablet was composed of 90% CMXG, a highly viscous polymer solution having considerable mechanical strength was formed around the tablet surface that acted as a barrier to diffusion of drug. Rapid formation of viscous polymer solution around the tablet surface and poor aqueous solubility of PDL were responsible to prevent initial burst effect. The viscous polymer layer becomes diluted with time and the polymer dissolves away or erodes from the surface promoting further penetration of water to hydrate the preceding layer of tablet surface. This sequence of events coupled with pH-independent solubility of PDL (209.37 mg/l in acid solution of pH 1.2 and 202.08 mg/l in buffer solution of pH 7.4 at 27°C) produced gradual drug release.
CaCl 2 , which was added in tablets FX2 to FX5, dissolved in water during the wet massing step of tablet preparation and generated Ca +2 ion. The liberated Ca +2 ion reacted with the carboxyl groups of CMXG in situ and thus cross-linked the free carboxyl group of CMXG. Similar ionic cross-link between Ca +2 ion and alginate (25, 26) , carboxymethyl guar (6, 27) , and pectin (11, 28) have been reported. The cross-link restricts the mobility of the polymer chains and results in the formation of a true gel layer in contact with water around the MDT mean dissolution time, SD standard deviation tablet surface (29) . Increase in cross-linking agent produces higher cross-link density inducing higher gel strength (28) and reduces macromolecular mesh size (30) and, hence, decreases drug diffusion through the gel layer. The diffusion coefficient of the drug from various tablet matrices through the viscous polymer solution or gel layer was determined based on Fickian diffusion model using Eq. (1), and the results are shown in Table II . Increase in the amount of CaCl 2 up to a certain level decreased the diffusion coefficient of the drug, and further increase in the amount of CaCl 2 increased the diffusion coefficient.
Increase in the amount of CaCl 2 in the tablets reduced the swelling of the matrices, and at the highest level of CaCl 2 , the matrix-swelling decreased considerably and erosion of the matrix started earlier (data not shown). These observations highlighted the effect of in situ crosslinking between a certain amount of Ca +2 ion and CMXG on retardation of drug release. The results are in agreement with the reports that increase in calcium content decreases the drug release from Ca +2 ion crosslinked pectin and alginate matrix tablets, and beyond a critical concentration of Ca +2 ion, drug release increases due to either weakening of the gel strength of the polymer caused by excessive cross-linking by Ca +2 ions resulting in a nonhomogenous pectin matrix (10, 31) or channeling effect of Ca +2 ions present in excess to that required for cross-linking of alginate (4) .
The effect of crushing strength (3.5 to 5.5 kg/cm 2 ) of tablets on drug release was studied on two sets of tablets prepared with CMXG/CaCl 2 in a ratio of 3:1 and 1.5:1. To compare the effect of crushing strength of tablets on drug release, area under the curves (AUCs) of release versus time curves were calculated using trapezoidal rule. Within a time period, decrease in the value of AUC is an indication of slower drug release and vice versa. Table III shows that increase in crushing strength of the tablets decreased the value of AUC.
This observation was found with both the tablet formulations prepared using CMXG and CaCl 2 in a ratio of 1.5:1 and 3:1. It has been reported that release of drugs from hydrophilic matrix tablets is independent of compression force as it is the gel porosity rather than the tablet porosity that determines the drug release (32) . Although inconclusive without further experimentation, it can be hypothesized that increase in compression force might have altered the swelling and erosion characteristics of the tablets inducing change in drug release. The results further substantiated the previous observation that increase in calcium content decreases the drug release as this phenomenon was observed in the tablets prepared with three different crushing strengths.
The effect of drug load on the release of PDL was studied with the tablets prepared using CMXG/CaCl 2 ratio of 1.5:1 and having a crushing strength of 5 kg/cm 2 . Table III shows that increase in drug load from 5 to 20 mg decreased the values of AUC. Generally, increase in drug content increases the concentration gradient of the drug between the tablet and external dissolution medium and results in higher drug release. However, the release of a drug from a polymer matrix depends not only on the diffusion of drug but also on relaxation of the polymer on solvent penetration. The solvent front penetration rate has been found to be the lowest in a matrix containing the highest drug content (33) . At low drug load, larger pore fraction results in higher swelling inducing faster drug release. On the other hand at higher drug load, the higher crystalline domain of the drug formed in the matrix causes reduction as well as shrinkage of pores in the matrix and produces slower drug release. Decrease in drug release with increase in drug load from bead-type dosage form has been reported (34) (35) (36) .
The gastric empting time of tablets may vary from 1 to 3 h depending on the physiological and disease condition as well as the presence or absence of food. The different exposure time in acid solution may change the characteristics of a matrix in which an acidic pendant group is introduced and subsequently cross-linked ionically. To assess the effect of variable exposure time in acid solution on overall drug release, the dissolution study of FX4 and FX5 tablets was conducted in acid solution for 0.5, 2, or 3 h, and after each specified time, the pH of the dissolution medium was changed to pH 7.4 and 6.8.
The drug release profiles of tablet FX4 (Fig. 5a ) after various pretreatment in acid solution indicated that as the residence time of the tablet in acid solution was increased, the drug release also increased. Similar observation was noted for tablet FX5 (Fig. 5b) . As the exposure time in acid solution was increased, conversion of Ca-CMXG to CMXG also increased. Subsequent increase in pH of dissolution medium accentuated the charge repulsion between the ionized carboxylic groups inducing increase in gel porosity and thus produced higher release.
Release Mechanism
In an attempt to evaluate the mechanism of drug release, the data up to 60% PDL release from various tablets were fitted in power law Eq. (2), and the results are shown in Table IV . Mechanism of drug release from uncross-linked and calcium-cross-linked CMXG tablets (FX1-FX4) was non-Fickian/anomalous as the values of the release exponent n were confined within 0.789 to 0.868. However, for tablet FX5, which was prepared with the highest amount of CaCl 2 , the mechanism of drug release was found to be super case II transport (n=1.032). The mechanism of drug release from tablets containing higher drug loads (FX4 and FX 13) and crushing strength (FX7,FX8 and FX10, FX11) were found to be anomalous except for tablets containing lowest drug load (FX13) and crushing strength (FX6 and FX9) that appeared to be super case II transport. Except for tablet FX5, increase in the amount of CaCl 2 , drug load, and tablet crushing strength decreased the kinetic constant (k) indicating increase in retardation of drug release.
CONCLUSION
PDL-loaded matrix tablets were developed by an industrially feasible wet granulation method using CMXG as a hydrophilic polymer which was cross-linked in situ with Ca +2 ions. Variables such as CMXG/CaCl 2 ratios, drug load, crushing strength, and pretreatment time in acid solution were found to modulate the drug release to a different extent. The study also revealed that the drug release from all the formulations was considerably less in 5 h, a time period during which the formulation are expected to cross the upper gastrointestinal region. However, none of the formulation, barring FX5, was able to release the loaded drug rapidly in 10 h during which the formulations might be located in the colon. The tablet FX5 which was prepared with CMXG/CaCl 2 ratio of 1:1 released major portion of the drug in 10 h although the premature release was slightly higher than the other formulations. It is concluded from the preliminary study that the tablet FX5 appears to be a promising formulation for further modification to design a device for colon delivery of drug. 
